FTDI
TARO

First Trust Direct Indexing’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

First Trust Direct Indexing’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,357
Closed -$214K – 694
2021
Q3 		$214K Buy
+3,357
New +$232K 0.03% 576

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

First Trust Direct Indexing's TARO Position: Q4 2021 in Review

First Trust Direct Indexing sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2021, closing a stake of 3,357 shares — an estimated $214K sold.

First Trust Direct Indexing first reported a position in TARO in Q3 2021 and held it in 1 quarter. The position peaked at $214K in Q3 2021. 71 funds tracked by Wall St. Rank hold TARO as of Q4 2021.

  • First Trust Direct Indexing reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2021 after selling out during the quarter.
  • First Trust Direct Indexing sold 3,357 Taro Pharmaceutical Industries Ltd. shares in Q4 2021, an estimated $214K.
  • First Trust Direct Indexing first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2021 and held it in 1 quarter.
  • First Trust Direct Indexing's Taro Pharmaceutical Industries Ltd. position peaked at $214K in Q3 2021.
  • 71 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2021.

Based on First Trust Direct Indexing's 13F filing for Q4 2021, filed 19 Jan 2022.